Document is current
Any future updates will be listed below
-
Authors
Hart, Trevor A. https://orcid.org/0000-0001-5107-7452
Berlin, Graham W. https://orcid.org/0000-0002-6209-348X
Deng, Yangqing
Noor, Syed https://orcid.org/0000-0002-4090-8799
Palma, Paolo https://orcid.org/0000-0002-1562-6087
Skakoon-Sparling, Shayna https://orcid.org/0000-0002-5021-6593
Wardell, Jeffrey D. https://orcid.org/0000-0001-9792-280X
Dermody, Sarah https://orcid.org/0000-0003-4998-6803
Tan, Darrell H. S. https://orcid.org/0000-0002-3069-2875
Grace, Daniel https://orcid.org/0000-0002-9032-3959
Lachowsky, Nathan J. https://orcid.org/0000-0002-6336-8780
Cox, Joseph https://orcid.org/0000-0002-7041-1556
Moore, David M. https://orcid.org/0000-0003-1078-9247
Lambert, Gilles
Zhang, Terri https://orcid.org/0000-0002-6696-0640
Dvorakova, Milada https://orcid.org/0000-0002-1808-8253
Lal, Allan
Jollimore, Jody https://orcid.org/0000-0002-6005-9720
,
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (TE2-138299, PJT-153139, FDN-143342)
Canadian Foundation for AIDS Research (Canadian Foundation for AIDS Research)
Ontario HIV Treatment Network (OHTN, #1051)
Public Health Agency of Canada (4500345082)
Toronto Metropolitan University (Toronto Metropolitan University)
- License Information
-
More Information
Article History
Accepted: 17 September 2024
First Online: 1 October 2024
Declarations
:
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
: TAH reports being an Advisory Committee member for the Canadian Institutes of Health Research (CIHR)’s Institute of Infection and Immunity and funds for community engagement events from ViiV Healthcare and Gilead Sciences Canada. DHST’s institution has received investigator-initiated grants from Abbvie and Gilead, and support for participation in clinical trials sponsored by Glaxo Smith Kline. Other authors declare that they no conflicts.
